Dipna Pharmachem Limited (BOM:543594)
5.44
-0.15 (-2.68%)
At close: Jul 15, 2026
Dipna Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 11.92 | 4.26 | 138.78 | 56.92 | 2.09 |
Short-Term Investments | - | 6.83 | 10.16 | 2.48 | - |
Cash & Short-Term Investments | 11.92 | 11.08 | 148.94 | 59.4 | 2.09 |
Cash Growth | 7.55% | -92.56% | 150.73% | 2746.89% | -17.59% |
Accounts Receivable | 480.05 | 462.76 | 309.37 | 285.32 | 269.75 |
Receivables | 480.05 | 1,017 | 752.36 | 511.41 | 269.85 |
Inventory | 423.25 | 274.35 | 373.82 | 189.43 | 63.04 |
Other Current Assets | 625.68 | 20.74 | 53.54 | 14.95 | 26.91 |
Total Current Assets | 1,541 | 1,323 | 1,329 | 775.2 | 361.88 |
Property, Plant & Equipment | 0.72 | 0.46 | 0.37 | 0.4 | 0.41 |
Long-Term Deferred Tax Assets | 0.07 | 0.03 | 0.03 | 0.01 | - |
Other Long-Term Assets | 2.96 | - | - | -0 | - |
Total Assets | 2,056 | 1,324 | 1,329 | 775.6 | 362.3 |
Accounts Payable | 1,103 | 658.43 | 706.46 | 352.39 | 230.3 |
Accrued Expenses | - | - | - | - | 8.7 |
Short-Term Debt | - | - | 1 | - | 43.91 |
Current Portion of Long-Term Debt | 31.11 | 83.33 | 67.98 | 49.38 | - |
Current Income Taxes Payable | 11.78 | 5.42 | 12.09 | 8.73 | 4.03 |
Current Unearned Revenue | - | 98.82 | 38.9 | 10.44 | - |
Other Current Liabilities | 185.95 | 3.97 | 1.98 | 1.39 | - |
Total Current Liabilities | 1,332 | 849.96 | 828.4 | 422.32 | 286.93 |
Long-Term Debt | 101 | 88.9 | 125.47 | 109.69 | 57.98 |
Other Long-Term Liabilities | 0 | - | -0 | -0 | - |
Total Liabilities | 1,433 | 938.86 | 953.87 | 532.02 | 344.91 |
Common Stock | 262.89 | 240.45 | 240.45 | 119.7 | 0.35 |
Additional Paid-In Capital | - | 113.26 | 113.26 | 113.26 | 2.25 |
Retained Earnings | - | 31.22 | 21.48 | 10.63 | 14.79 |
Comprehensive Income & Other | 360.14 | - | - | - | - |
Shareholders' Equity | 623.03 | 384.93 | 375.19 | 243.58 | 17.39 |
Total Liabilities & Equity | 2,056 | 1,324 | 1,329 | 775.6 | 362.3 |
Total Debt | 132.11 | 172.23 | 194.45 | 159.08 | 101.89 |
Net Cash (Debt) | -120.19 | -161.15 | -45.51 | -99.67 | -99.8 |
Net Cash Per Share | -4.57 | -6.78 | -3.77 | -8.31 | -594.06 |
Filing Date Shares Outstanding | 25.51 | 24.05 | 24.05 | 11.97 | 7.97 |
Total Common Shares Outstanding | 25.51 | 24.05 | 24.05 | 11.97 | 0.17 |
Working Capital | 208.64 | 473.34 | 500.26 | 352.87 | 74.95 |
Book Value Per Share | 24.42 | 16.01 | 15.60 | 20.35 | 103.48 |
Tangible Book Value | 623.03 | 384.93 | 375.19 | 243.58 | 17.39 |
Tangible Book Value Per Share | 24.42 | 16.01 | 15.60 | 20.35 | 103.48 |
Machinery | - | 1.24 | 1.04 | 0.89 | 0.79 |